News
News releases on December 12, 2021
Every news release public companies put out on December 12, 2021 (UTC): 20 news releases, newest first. Open any release to read it.
Cochlear: 2021 Modern Slavery Statement
CochLear Limited · Dec 12, 2021
Alantra Partners S A announces ten promotions to partner
Alantra Partners SA · Dec 12, 2021
Novatti: Proposed issue of securities - NOV
Novatti Group Ltd. · Dec 12, 2021
New Talisman Gold Mines: Half Yearly Report and Accounts
New Talisman Gold Mines Limited · Dec 12, 2021
Crews out in full force as wind storm knocks out power to approximately 450,000 customers; nearly 115,000 customers still without power
Hydro One Limited · Dec 12, 2021
New Zinc-Lead-Silver Discovery at Earaheedy Project
Rumble Resources Limited · Dec 12, 2021
Titan Minerals: Amended - Drilling Commences at Copper Duke Project
Titan Minerals Ltd · Dec 12, 2021
Xencor Presents Data from Phase 1 Study of Plamotamab in B-cell Non-Hodgkin Lymphomas at the ASH Annual Meeting
Xencor, Inc. · Dec 12, 2021
Sangamo Therapeutics Announces Updated Preliminary SAR445136 Phase 1/2 Proof-of-Concept Data Showing Tolerability and Sustained Effects i...
Sangamo Therapeutics, Inc. · Dec 12, 2021
Sana Biotechnology Presentations at 2021 ASH Annual Meeting Highlight Progress with Platforms and CAR T Cell Programs
Sana Biotechnology, Inc. · Dec 12, 2021
Protagonist Therapeutics Presents Updated Phase 2 Rusfertide Data in Polycythemia Vera (PV) at ASH 2021 Annual Meeting
Protagonist Therapeutics, Inc. · Dec 12, 2021
Pfizer and Sangamo Announce Updated Phase 1/2 Results Showing Sustained Bleeding Control in Highest Dose Cohort Through Two Years Followi...
Sangamo Therapeutics, Inc. · Dec 12, 2021
Nurix Therapeutics Announces Regulatory Clearance to Initiate Phase 1 Clinical Trial of NX-5948 and Presents New Preclinical Data at the ...
Nurix Therapeutics, Inc. · Dec 12, 2021
Jazz Pharmaceuticals Presents Positive Interim Phase 2/3 Results of Rylaze™ (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acu...
Jazz Pharmaceuticals plc · Dec 12, 2021
Editas Medicine Reports Preclinical Data Demonstrating Robust Tumor Reduction and Clearance Using Novel, Engineered iNK Cells at the Amer...
Editas Medicine, Inc. · Dec 12, 2021
Dollar Tree Sets the Record Straight Regarding Recent Engagement with Mantle Ridge; Comments on Mantle Ridge’s Notice of Nomination of Di...
Dollar Tree, Inc. · Dec 12, 2021
CSG SaaS Platform Earns Frost & Sullivan Product Leadership Award for Innovative Technology and Unparalleled Customer Experiences
CSG Systems International, Inc. · Dec 12, 2021
Beam Therapeutics Outlines Long-term Strategy for Base Editing Programs in Sickle Cell Disease and Provides Preclinical Data Updates at ASH
Beam Therapeutics Inc. · Dec 12, 2021
ALX Oncology Announces Initial Data from ASPEN-02, the Ongoing Phase 1 / 2 Study of Evorpacept in Combination with Azacitidine, Demonstra...
ALX Oncology Holdings Inc. · Dec 12, 2021
Extreme winds knock out power to 280,000 customers; nearly 210,000 customers still without power
Hydro One Limited · Dec 12, 2021